# Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy

> **NCT00629018** · PHASE2 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 110 (actual)

## Conditions studied

- Dilated Cardiomyopathy

## Interventions

- **BIOLOGICAL:** CD34+ autologous stem cell transplantation
- **DRUG:** Bone Marrow Stimulation
- **BIOLOGICAL:** SC therapy

## Key facts

- **NCT ID:** NCT00629018
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2015-05-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00629018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00629018, "Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00629018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*